Janssen's Cilta-Cel CAR T Receives FDA Approval for Relapsed Multiple Myeloma

Posted by

HealthTree

A New AML Chemo Drug in Development with Less Heart Complications and Minimal Hair Loss

Posted by

HealthTree

Introducing HealthTree Moves: A Fitness Tracking App for the Multiple Myeloma Community

Posted by

HealthTree

A Group for Non-Secretory Myeloma Patients, Finally!

Posted by

HealthTree

New Moves Challenge for Myeloma Awareness Month

Posted by

HealthTree

Full Adult AML Chapter Event: Long Term Survivorship after Stem Cell Transplant with Ilana Massi

Posted by

HealthTree

Can MRD Testing Be Used to Determine Multiple Myeloma Therapy Changes?

Posted by

HealthTree

Acting Assertive vs. Aggressive as an Acute Myeloid Leukemia Patient

Posted by

HealthTree

How Does Dialysis Impact Multiple Myeloma Treatment?

Posted by

HealthTree

Antibody Study Highlights Heidelberg Myeloma Agenda

Posted by

HealthTree